Lamuka opposition coalition warns against ‘two‑tier democracy’ in DR Congo



Despite this historic progress, the sector has faced a recent slowdown, with a decline in the pace of new projects over the past year.
• Cumulative investments: over BRL 300 billion;
• Jobs created: over 2 million in the past decade;
• Installed capacity: 68.6 gigawatts (GW) in operation;
• Public revenue: BRL 95.9 billion;
• Share of the electricity mix: 25.3% (the country’s second-largest source).
This growth is occurring despite a significant decline in 2025. According to the survey, the capacity added to the energy grid fell by 25.6 percent, from 15.6 GW in 2024 to 11.6 GW the following year.
Solar energy is spreading across Brazil, with large-scale plants in various regions and distributed generation systems (small plants and rooftops) installed in more than 5,000 municipalities.
• São Paulo: 6.5 GW;
• Minas Gerais: 5.8 GW;
• Paraná: 4.2 GW.
According to ABSOLAR’s assessment, recent obstacles have limited the sector’s growth potential, resulting in business closures, canceled investments, and job losses. According to Barbara Rubim, the association’s president-elect for the 2026–2030 term, the priority will be to promote the sustainable expansion of solar energy, focusing on regulatory improvements, strengthening the free energy market, and incentivizing complementary technologies such as energy storage and green hydrogen.
Among the main points advocated by the association is the regulation of electricity storage under the Special Incentive Regime for Infrastructure Development (REIDI). According to the association, this can be implemented through administrative regulations - via presidential decrees or ministerial ordinances - without the need for congressional approval of bills or provisional measures.
The organization also advocates for changes to promote solar energy storage projects under the special tax regime for sectors included in the tax reform.
Founded in 2013, ABSOLAR brings together companies and institutions across the photovoltaic energy chain and works to coordinate the sector in support of Brazil’s energy transition.
He had been hospitalized at the DF Star Hospital in Brasília since last Friday (May 1).
Jair Bolsonaro’s surgery was an arthroscopic repair of the rotator cuff to treat injuries confirmed by imaging tests and a physical therapy report. The procedure was authorized by Supreme Court Justice Alexandre de Moraes, following a favorable opinion from Attorney General Paulo Gonet.
Bolsonaro, 71, has been under humanitarian house arrest since March 24, following a decision by Alexandre de Moraes after he was hospitalized for bacterial pneumonia. The former president was sentenced by the First Panel of the Supreme Court in September 2025 to 27 years and 3 months in prison for his leading role in the coup plot.



With this authorization, the vaccine can now be incorporated into the country’s public healthcare network, the SUS. It is indicated for people aged 18 to 59 who have been exposed to the virus.
“This is another important milestone for the Butantan Institute and for public health. By carrying out most of the manufacturing process, the institute, as a public institution, will be able to deliver the vaccine at a lower, more affordable price, with the same quality and safety,” said the institute’s director, Esper Kallás.
At least 4,000 volunteers, aged 18 to 65, received the vaccine in the United States and were evaluated. According to results published in the medical journal The Lancet in 2023, 98.9 percent of participants produced neutralizing antibodies.
The vaccine was well tolerated and showed a favorable safety profile, with adverse events that were generally mild to moderate, most commonly headache, body aches, fatigue, and fever.
In February 2026, the vaccine began to be administered through the SUS in municipalities with high disease incidence, as part of a pilot strategy by the Ministry of Health. In addition to Brazil, the chikungunya vaccine has been approved in Canada and Europe.
The chikungunya virus is transmitted by the bite of the Aedes aegypti mosquito, which also transmits dengue and Zika.
The disease can cause sudden-onset fever (above 38.5°C) and severe pain in the joints of the feet and hands - such as the fingers, ankles, and wrists. Other common symptoms include headache, muscle pain, and red spots on the skin.
According to the Pan American Health Organization, 500,000 cases of chikungunya were reported worldwide in 2025.
In Brazil, more than 127,000 cases and 125 deaths were reported in the same year, according to the Ministry of Health.
The disease causes chronic joint pain, which can last for months to years and severely affect quality of life.
